Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

serine/threonine Kinase 17b (STK17B) (C-Term) Peptide

STK17B Reactivité: Humain BP Sodium azide
N° du produit ABIN1382031
  • Antigène Tous les produits DRAK2 (STK17B)
    DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
    Protein Region
    C-Term
    Origine
    Humain
    Application
    Blocking Peptide (BP)
    Attributs du produit
    15 amino acids near the carboxy terminus of human DRAK2.
    Human
  • Indications d'application
    DRAK2 peptide is used for blocking the activity of DRAK2.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    200 μg/mL
    Buffer
    PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Date de péremption
    12 months
  • Antigène
    DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
    Synonymes
    zgc:65989 Peptide, STK17B Peptide, DRAK2 Peptide, Drak2 Peptide, 3110009A03Rik Peptide, AI120141 Peptide, serine/threonine kinase 17b (apoptosis-inducing) Peptide, serine/threonine kinase 17b Peptide, stk17b Peptide, STK17B Peptide, Stk17b Peptide
Vous êtes ici:
Support technique